MED21 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.203000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.243200E-01
Normal-vs-Stage2
5.342600E-01
Normal-vs-Stage3
6.140800E-01
Normal-vs-Stage4
2.267000E-01
Stage1-vs-Stage2
6.053800E-01
Stage1-vs-Stage3
1.170430E-01
Stage1-vs-Stage4
3.654000E-01
Stage2-vs-Stage3
1.994800E-01
Stage2-vs-Stage4
8.951900E-02
Stage3-vs-Stage4
1.004820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.254600E-01
Normal-vs-AfricanAmerican
5.636800E-01
Normal-vs-Asian
7.095800E-01
Caucasian-vs-AfricanAmerican
9.259000E-01
Caucasian-vs-Asian
7.083800E-01
AfricanAmerican-vs-Asian
8.771600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.838000E-01
Normal-vs-Female
5.874000E-01
Male-vs-Female
2.608000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.523800E-01
Normal-vs-Age(41-60Yrs)
2.635400E-01
Normal-vs-Age(61-80Yrs)
6.977400E-01
Normal-vs-Age(81-100Yrs)
8.581800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.161800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.013220E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.150000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.862330E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.860400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.551000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.907000E-01
Normal-vs-Daily Drinker
7.599600E-01
Normal-vs-Weekly Drinker
8.884400E-01
Normal-vs-Occasional Drinker
2.260800E-01
Normal-vs-Social Drinker
5.051600E-01
Non Drinker-vs-Daily Drinker
7.150400E-01
Non Drinker-vs-Weekly Drinker
8.869000E-01
Non Drinker-vs-Occasional Drinker
1.577870E-02
Non Drinker-vs-Social Drinker
3.085400E-01
Daily Drinker-vs-Weekly Drinker
7.061600E-01
Daily Drinker-vs-Occasional Drinker
1.536010E-01
Daily Drinker-vs-Social Drinker
6.869800E-01
Weekly Drinker-vs-Occasional Drinker
6.040400E-02
Weekly Drinker-vs-Social Drinker
3.888200E-01
Occasional Drinker-vs-Social Drinker
2.735000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.034480E-02
Normal-vs-Grade 2
5.937300E-03
Normal-vs-Grade 3
6.037400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.978600E-01
Grade 1-vs-Grade 3
1.335850E-01
Grade 1-vs-Grade 4
1.034480E-02
Grade 2-vs-Grade 3
1.617830E-01
Grade 2-vs-Grade 4
5.937300E-03
Grade 3-vs-Grade 4
6.037400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.686000E-01
Normal-vs-NonDiabetic
5.499000E-01
Diabetic-vs-NonDiabetic
4.564800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.019000E-01
Normal-vs-NoPancreatitis
5.633400E-01
Pancreatitis-vs-NoPancreatitis
6.158200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.366800E-01
Normal-vs-N1
5.228600E-01
N0-vs-N1
9.284600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.831400E-01
Normal-vs-TP53-NonMutant
5.082400E-01
TP53-Mutant-vs-TP53-NonMutant
7.286500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
